Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.43p
   
  • Change Today:
    -0.026p
  • 52 Week High: 3.96
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 3,614,132
  • Market Cap: £19.12m
  • RiskGrade: 340

Regulatory News

Posting of Annual Report & Notice of AGM 03-Jun-2024 07:00 RNS
Final Results 25-Apr-2024 07:00 RNS
Total Voting Rights 28-Mar-2024 07:00 RNS
Placing to Raise US$4.2 million 29-Feb-2024 07:00 RNS
CBR Brain Delivery 16-Feb-2024 07:00 RNS
CBR Intranasal Delivery 14-Feb-2024 07:00 RNS
FDA Consents to Phase I Trials of HEMO-CAR-T 09-Feb-2024 07:00 RNS
Approval and Issuance of U.S. Conditioning Patent 02-Feb-2024 07:00 RNS
Submission of Complete Response to Clinical Hold 16-Jan-2024 07:00 RNS
HEMO-CAR-T Process Qualification Run Completed 08-Jan-2024 07:00 RNS
Placing to Raise £534,375 28-Nov-2023 12:19 RNS
CBR Expanded to Treatment of Cancer 27-Nov-2023 07:00 RNS
Lentivirus Re-manufacturing Completed 15-Nov-2023 07:00 RNS
Total Voting Rights 31-Oct-2023 07:00 RNS
Half-year Report 28-Sep-2023 12:28 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.43p
Change Today -0.026p
% Change -1.79 %
52 Week High 3.96
52 Week Low 1.23
Volume 3,614,132
Shares Issued 1,341.82m
Market Cap £19.12m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.26% below the market average50.26% below the market average50.26% below the market average50.26% below the market average50.26% below the market average
68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average
Price Trend
11.96% above the market average11.96% above the market average11.96% above the market average11.96% above the market average11.96% above the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:55 10,402 @ 1.43p
15:53 150,000 @ 1.41p
15:53 84,319 @ 1.41p
15:04 100,000 @ 1.43p
15:04 337 @ 1.40p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page